Quarterly report pursuant to Section 13 or 15(d)

CONSOLIDATED BALANCE SHEETS

v3.24.1.u1
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
ASSETS    
Available-for-sale securities, at fair value (amortized cost $8,467,938 and $8,509,383, respectively; allowance for credit losses $3,607 and $3,943, respectively) $ 8,182,544 $ 8,327,149
Mortgage servicing rights, at fair value 3,084,879 3,052,016
Cash and cash equivalents 666,244 729,732
Restricted cash 72,184 65,101
Accrued interest receivable 35,487 35,339
Due from counterparties 545,312 323,224
Derivative assets, at fair value 24,397 85,291
Reverse repurchase agreements 351,843 284,091
Other assets 199,035 236,857
Total Assets 13,161,925 13,138,800
Liabilities    
Repurchase agreements 8,361,638 8,020,207
Revolving credit facilities 1,357,671 1,329,171
Term notes payable 295,520 295,271
Convertible senior notes 268,953 268,582
Derivative liabilities, at fair value 3,027 21,506
Due to counterparties 330,551 574,735
Dividends payable 58,685 58,731
Accrued interest payable 79,990 141,773
Commitments and contingencies (see Note 16) 0 0
Other liabilities 165,820 225,434
Total Liabilities 10,921,855 10,935,410
Stockholders' Equity    
Preferred stock, par value $0.01 per share; 100,000,000 shares authorized and 24,870,817 and 25,356,426 shares issued and outstanding, respectively ($621,770 and $633,911 liquidation preference, respectively) 601,467 613,213
Common stock, par value $0.01 per share; 175,000,000 shares authorized and 103,474,944 and 103,206,457 shares issued and outstanding, respectively 1,035 1,032
Additional paid-in capital 5,931,558 5,925,424
Accumulated other comprehensive loss (279,507) (176,429)
Cumulative earnings 1,554,205 1,349,973
Cumulative distributions to stockholders (5,568,688) (5,509,823)
Total Stockholders’ Equity 2,240,070 2,203,390
Total Liabilities and Stockholders’ Equity $ 13,161,925 $ 13,138,800